VBI Vaccines Announces Positive DSMB Review in Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma (GBM) Patients


You May Also Like

Biothera Pharmaceuticals Appoints Andrew D.C. LaFrence Chief Financial Officer

EAGAN, Minn., May 16, 2018 (GLOBE NEWSWIRE) -- Biothera Pharmaceuticals, Inc., announced the appointment ...

Johanna Ivaska has been appointed Head & Vice President of Oncology Research in Orion Corporation

 ORION CORPORATION                                            PRESS RELEASE                      10 SEPTEMBER 2018 Johanna Ivaska has been appointed Head & ...